accountwas largely responsible for the surprisingly strong sales -- a factor that has also bolstered first-quarter results for Eli Lilly (LLY.N Shares of Abbott were up 0.8 percent at $51.49 in early trading. Sales of Humira, the company's biggest product, rose...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 3-Humira fuels Abbott sales growth
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account